Canada is seeking to collect information from companies on their liquid manufacturing and process development capacity to meet a Government of Canada (GOC) requirement for a unique formulation of diluent (Phenol Phosphate-Citrate based Buffer with 45% Glycerol) in 2 mL glass vials and empty 2mL sterile glass vials with a removable cap enclosure system capable of being re-stoppered.
AI Analysis
Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.
Basic information
Reference
WS4617512505-Doc4617645456
Solicitation no.
WS4617512505
Buyer
Department of Public Works and Government Services (PSPC)
Suppliers who have won similar work from this buyer before.
1
BOEHRINGER INGELHEIM ANIMAL HEALTH
2 contracts won· latest May 28, 2025
CAD $36.2M
total awarded
2
Moderna Biopharma Canada Corporation
1 contract won· latest June 30, 2025
CAD $360.5M
total awarded
3
Pfizer Canada ULC
1 contract won· latest January 25, 2023
CAD $39.5M
total awarded
4
SANOFI PASTEUR LIMITED/SANOFI PASTEUR LIMITEE
1 contract won· latest March 30, 2026
CAD $37.8M
total awarded
5
Emergent Product Development Gaithersburg Inc
1 contract won· latest February 25, 2026
CAD $34.2M
total awarded
BOEHRINGER INGELHEIM ANIMAL HEALTH is the most likely incumbent, based on how often and how recently they have won this buyer’s work in this category. To displace them, expect to need a clearly stronger proposition or price.
